Press Releases June 4, 2026 06:00 AM

InterPrivate Investment Partners V, Inc. Announces Pricing of $175 Million Initial Public Offering

InterPrivate Investment Partners V, Inc. announces pricing and details of its $175 million IPO on Nasdaq trading under ticker IPVVU.

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
IPVVU

InterPrivate Investment Partners V, Inc., a blank check company focused on effecting mergers or acquisitions, priced its initial public offering of 17.5 million units at $10 per unit, raising $175 million. Units will trade on Nasdaq under ticker IPVVU, with underlying shares and warrants trading separately under IPVV and IPVVW. The company aims to leverage its management's private equity, technology, and digital asset expertise to find a high-quality business combination target.

InterPrivate Investment Partners V, Inc. Announces Pricing of $175 Million Initial Public Offering
IPVVU
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • InterPrivate Investment Partners V, Inc. priced its IPO at $175 million, issuing 17.5 million units at $10 each.
  • Units include one Class A share and one-third of a warrant, with full warrants exercisable at $11.50, enhancing potential future capital.
  • The company targets business combinations leveraging management’s expertise in private equity, technology, and digital assets, affecting investment and fintech sectors.

New York, NY, June 04, 2026 (GLOBE NEWSWIRE) --   InterPrivate Investment Partners V, Inc. (the “Company”), a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, announced the pricing of its initial public offering of 17,500,000 units at a price of $10.00 per unit on June 3, 2026. The units are expected to be listed for trading on the Nasdaq Global Market under the ticker symbol “IPVVU” beginning June 4, 2026. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant of the Company. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. Once the securities comprising the units begin separate trading, the Company expects that its Class A ordinary shares and warrants will be listed on the Nasdaq Global Market under the symbols “IPVV” and “IPVVW,” respectively. The offering is expected to close on June 5, 2026, subject to customary closing conditions.
  
Cantor Fitzgerald & Co. is acting as the sole book-running manager for the offering. EarlyBirdCapital, Inc. is acting as co-manager. The Company has granted the underwriters a 45-day option to purchase up to 2,625,000 additional units at the initial public offering price to cover over-allotments, if any.

The public offering is being made only by means of a prospectus. When available, copies of the prospectus relating to the offering may be obtained from Cantor Fitzgerald & Co., 499 Park Avenue, New York, New York 10022, Attention: General Counsel, or by email at: [email protected].

A registration statement relating to the securities became effective on June 3, 2026. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About InterPrivate Investment Partners V, Inc.

InterPrivate Investment Partners V, Inc. is a blank check company organized for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company is controlled by affiliates of Ahmed M. Fattouh, Chairman and Chief Executive Officer, and is also led by Lex Sokolin, President; Brandon Bentley, General Counsel; Dimitri Goulandris and Nick Krenteras, Directors.  The Company intends to leverage its management team’s broad experience and relationships across private equity, technology and digital assets to identify and consummate an initial business combination with a high-quality target business that can benefit from access to the public capital markets and from the experience, relationships and execution capabilities of its sponsor and management team. The Company is an emerging growth company as defined in the Jumpstart Our Business Startups Act of 2012. 

Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the proposed initial public offering and the anticipated use of the net proceeds from the offering. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the Company will ultimately complete a business combination transaction. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and preliminary prospectus for the Company’s offering filed with the U.S. Securities and Exchange Commission (the “SEC”). Copies of these documents are available on the SEC’s website, at www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Contact

InterPrivate Investment Partners V, Inc.

Brandon Bentley, General Counsel

[email protected]

[email protected]

www.interprivate.com


Risks

  • No guarantee that the company will complete a business combination transaction, creating uncertainty on the use of proceeds and future growth.
  • Market conditions or regulatory approvals may delay or prevent the offering or subsequent acquisition, posing operational risks.
  • As a blank check company (SPAC), the investment is subject to risks associated with identifying a suitable merger partner within a specified timeframe, impacting potential investor returns.

More from Press Releases

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 5, 2026 Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of MannKind’s Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with Automated Insulin Delivery (AID) Systems Jun 5, 2026 Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study Jun 5, 2026 Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026 Jun 5, 2026 B2Gold Announces Voting Results from its 2026 Annual General and Special Meeting Jun 5, 2026